In August 2014, the SAMRC and PATH formed the Global Health Innovation Accelerator (GHIA) as a partnership to address the gaps and barriers in the health innovation ecosystem in South Africa and to enhance the ability of both organizations to meet their respective mandates. GHIA is aimed at facilitating the late stage development and introduction of affordable and appropriate technologies in South Africa and Africa more broadly.
GHIA combines the local context experience and networks, human and financial resources and research and development project portfolio of the SAMRC with PATH’s in-house product development and commercialization expertise, network of international health technology companies, international footprint in developing countries and global funding and advocacy network. GHIA’s value proposition is thus the combination of offerings from two reputable organisations with demonstrated success in utilizing resources to drive health impact and commercialization.
The ultimate goal of GHIA's work is to strengthen the health innovation ecosystem in South Africa, to deliver new health solutions, and to drive positive social health impact through its programs and projects.
For funders, GHIA offers the potential to de-risk projects and to enhance the probability of success by presenting projects that have been through a thorough due diligence process, that respond to a clear market need, that are technically sound and backed by strong academic networks, and that are rigorously managed by experienced project managers to deliver on defined milestones. GHIA also addresses social imperatives by focusing on technologies aimed at improving health outcomes for vulnerable populations.
Core support for GHIA has been provided through a grant from the Bill & Melinda Gates Foundation and in-kind contributions from the SAMC and PATH.